← Back to Search

Text-Messaging (TM) for Coronavirus

N/A
Waitlist Available
Led By Guilherme Del Fiol, MD, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2 years.
Awards & highlights

Study Summary

This trial is testing two interventions to increase uptake of the COVID-19 vaccine among patients at community health centers in Utah. The first intervention is a text messaging system that automatically identifies patients eligible for the vaccine and helps them connect to a vaccination site. The second intervention is patient navigation, which involves motivating and helping patients with logistics and barriers to getting the vaccine. The trial will use a rapid cycle research approach, implementing the interventions in a small number of clinics and patients, and then adapting or disseminating the results based on the results of the evaluation.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Uptake-Eligible (vaccination)
Secondary outcome measures
Reach-PN Engage
Reach-TM Engage
Uptake-Total

Trial Design

2Treatment groups
Active Control
Group I: Text-Messaging (TM)Active Control1 Intervention
Population health management intervention that analyzes electronic health record data to automatically identify participants who are eligible for the COVID-19 vaccine and proactively reach those participants for vaccine scheduling. This is a bi-directional text messaging system.
Group II: Text-Messaging plus Patient NavigationActive Control2 Interventions
Population health management intervention that includes the same bi-directional text-messaging system as Arm 1 (the text messaging condition) with the addition of patient navigation. Patient navigation includes real-time assistance from a community health worker to address barriers, provide motivation, and assist with logistics of COIVD vaccination.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,098 Previous Clinical Trials
1,668,467 Total Patients Enrolled
Association for Utah Community HealthOTHER
3 Previous Clinical Trials
194,301 Total Patients Enrolled
Utah Department of HealthOTHER
6 Previous Clinical Trials
369,958 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any fresh enrollees being taken into this experiment?

"According to the clinicaltrials.gov database, this medical trial is no longer recruiting participants. It was initially posted on March 29th 2021 and last edited June 24th 2022. Despite not being a viable option for patients right now, there are 1040 other trials actively searching for volunteers at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers
David Wetter 2021. "SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04939519.
~27541 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top